Low-Volume Cardioplegia and Myocardial Protection in Coronary Artery Bypass Graft Surgery.
Biomarkers
/ blood
Cardioplegic Solutions
/ administration & dosage
Coronary Artery Bypass
/ adverse effects
Coronary Stenosis
/ blood
Creatine Kinase, MB Form
/ blood
Databases, Factual
Extracorporeal Circulation
/ adverse effects
Female
Heart Arrest, Induced
/ adverse effects
Humans
Male
Myocardial Reperfusion Injury
/ blood
Potassium Compounds
/ administration & dosage
Risk Factors
Time Factors
Treatment Outcome
Troponin T
/ blood
Journal
The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
3
8
2018
medline:
18
12
2019
entrez:
3
8
2018
Statut:
ppublish
Résumé
We studied myocardial protection during coronary artery bypass graft surgery using low-volume cardioplegia (Cardioplexol) and minimal extracorporeal circulation (MECC) for different types of coronary artery diseases. In total, 426 consecutive patients were included and divided into four groups: those with left main stem stenosis (
Identifiants
pubmed: 30071564
doi: 10.1055/s-0038-1667322
doi:
Substances chimiques
Biomarkers
0
Cardioplegic Solutions
0
Potassium Compounds
0
Troponin T
0
potassium cardioplegic solution
0
Creatine Kinase, MB Form
EC 2.7.3.2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484-487Informations de copyright
Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
Disclosure The authors report no conflicts of interest in this work.